Loading viewer...
investor_presentation
Format: PDF investor_presentation
Lenzing AG presents half-year 2022 results with revenue of EUR 1,294 million and EBITDA of EUR 189 million. The presentation highlights ramp-up progress on new production facilities in Thailand and Brazil, strategic focus on profitable growth and circularity, and revised 2027 financial targets amid challenging market conditions.
investor_presentation
9 Pages
investor_presentation
33 Pages
Oncolytics Biotech